Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease. Impact of Antirheumatic Treatment on Antibody Response.

NCT03762824 is registered in ClinicalTrials.gov with Region Skane as lead sponsor.

NCT NCT03762824
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03762824 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Combined Pneumococcal Conjugate and Polysaccharide Vaccination in Inflammatory Rheumatic Disease. Impact of Antirheumatic Treatment on Antibody Response.
Lead sponsor
Region Skane
Phase
Phase 4
Overall status
Completed
Start date
June 14, 2016
Completion date
December 21, 2020
Enrollment
300 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis, sjögren syndrome, spondyloarthritis, systemic lupus, systemic vasculitis